Clinical Advisory Board
The mission of the IAPMD Clinical Advisory Board (CAB) is to improve the lives of people affected by premenstrual mood disorders (PMDs) by 1. educating and empowering health professionals to provide high quality, evidence-based, and patient-centered services in the diagnosis and treatment of PMDs, and 2. supporting patients affected by PMDs with the tools and resources for education, self-assessment, symptom management, and accessing quality care.
If you are interested in joining the IAPMD Clinical Advisory Board, we firstly recommend that you become an active member of the IAPMD Professional Community.
Dr. Melissa Wagner - USA
Clinical Assistant Professor of Psychiatry & Co-Medical Director of Adult Inpatient Psychiatric Services at the University of Cincinnati.
She completed her MD and Ph.D. as part of the Medical Scientist Training Program at the Medical College of Wisconsin in 2012 with a scientific focus on Neuroscience. Her post-graduate clinical training encompassed completion of residency in a triple board training program at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati, where she received training and board certification in pediatrics, general psychiatry, and child and adolescent psychiatry. Following residency, Dr. Wagner took an academic attending psychiatrist position as a reproductive psychiatrist and, through peer supervision and clinical and research collaborations, gained expertise in treating patients with mental illness during times of hormonal transitions. These times of hormone transition include prior to, during, and after pregnancy, mental health disorders related to hormone changes or the menstrual cycle, including perimenstrual dysphoric disorder (PMDD) and menopause, and mental health disorders related to or affecting fertility. Her triple board training serves as a significant asset in bridging the clinical gaps between reproductive psychiatry and family mental health. Dr. Wagner collaborates with internists, obstetricians, reproductive psychiatrists, and psychologists at both the University of Cincinnati and the University of Illinois with an academic focus that includes developing innovative care delivery models to help improve the diagnosis and treatment of reproductive-related mental illnesses and research involving PMDD, suicide risk, and neurosteroids. Finally, Dr. Wagner is clinically active in both psychiatry and pediatrics and serves as a supervising pediatrician within a Medicine-Pediatrics resident clinic at the University of Cincinnati and as the collaborative care reproductive and child psychiatrist in an innovative two-generation clinic within the internal medicine/pediatrics department at the University of Illinois in Chicago.